Skip to Content

DAN A22 (RANITIDINE 150 mg)

Pill imprint DAN A22 has been identified as Ranitidine hydrochloride 150 mg.

Ranitidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; eczema; gastric ulcer maintenance treatment (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ranitidine hydrochloride 150 mg DAN A22  Front
Ranitidine hydrochloride 150 mg DAN A22  Back
Discount Card Promo
Ranitidine hydrochloride
Imprint:
DAN A22
Strength:
150 mg
Color:
Yellow
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Schein

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide